18:20 IST
BSE
Earnings Call
Healthcare Global Enterprises Earnings Call Transcript: Key Takeaways
HCG reported a strong Q1FY27 with 13% YoY revenue growth and 20% EBITDA growth, driven by volume and improved payor mix.
Healthcare Global Enterprises Ltd
- Share price
- ₹698.65
- Market cap
- ₹10,431 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 457.5×Sector 57.8×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
20:40 IST
BSE
Earnings Call
Healthcare Global Enterprises Investor Presentation: Key Takeaways
HCG reported strong Q1 FY27 results with 13% YoY revenue growth and 20% Adjusted EBITDA growth. Strategic focus on oncology and capacity expansion through a new North Bengaluru facility.
15:24 IST
NSE
Earnings Call
Healthcare Global Enterprises Earnings Call: Key Takeaways
HCG delivered strong FY26 performance with 15% revenue growth and margin expansion. Strategy focuses on oncology core through the sale of fertility unit Milann and brownfield expansion.
17:49 IST
NSE
Earnings Call
Healthcare Global Enterprises Earnings Call: Key Takeaways
HCG delivered strong FY26 results with 15% revenue growth and margin expansion to 18.5%, driven by operational leverage and clinical excellence.
23:27 IST
BSE
Earnings Call
Healthcare Global Enterprises Earnings Call: Key Takeaways
HCG reported FY26 revenue of INR 25.4bn (up 15% YoY) and Adj. EBITDA of INR 4.7bn (up 19% YoY), driven by network productivity and operational leverage.